AJCN EB Program 2010 Early Registration
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Clinical Nutrition, doi:10.3945/ajcn.2008.25906
Vol. 88, No. 6, 1485-1494, December 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rambod, M.
Right arrow Articles by Kalantar-Zadeh, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rambod, M.
Right arrow Articles by Kalantar-Zadeh, K.
Agricola
Right arrow Articles by Rambod, M.
Right arrow Articles by Kalantar-Zadeh, K.
© 2008 American Society for Clinical Nutrition

Nutritional status, dietary intake, and body composition

Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis1,2,3,4

Mehdi Rambod1, Csaba P Kovesdy1, Rachelle Bross1, Joel D Kopple1 and Kamyar Kalantar-Zadeh1

1 From the Harold Simmons Center for Kidney Disease Research and Epidemiology (MR and K-Z), the Division of Nephrology and Hypertension (MR, JDK, and KK-Z), and the Bionutrition Services (RB), General Clinical Research Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA; the Salem Veterans Administration Medical Center, Salem, VA (CPK); and the School of Public Health, University of California, Los Angeles, CA (JDK and KK-Z)

2 Parts of this study were presented in the form of abstracts, poster, and oral presentations during the annual meetings of the National Kidney Foundation, April 4–8, 2008, Dallas, TX, and during Clinical Nutrition Week, February 10–13, 2008, Chicago, IL.

3 Supported by the National Institutes of Health, National Institute of Diabetes, Digestive, and Kidney Disease (grants K23DK61162 and R21DK078012), investigator-initiated research grant from Watson and DaVita, and a research grant from the philanthropist Mr. Harold Simmons (all for KK-Z), and the General Clinical Research Center from the National Centers for Research Resources, National Institutes of Health (grant M01RR00425).

4 Address reprint requests to K Kalantar-Zadeh, Harold Simmons Center for Kidney Disease Research and Epidemiology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, 1124 West Carson Street, C1-Annex, Torrance, CA 90502. E-mail: kamkal{at}ucla.edu.

Background: In patients receiving maintenance hemodialysis (MHD), a low serum prealbumin is an indicator of protein-energy wasting.

Objective:We hypothesized that baseline serum prealbumin correlates independently with health-related quality of life (QoL) and death and that its change over time is a robust mortality predictor.

Design: Associations and survival predictability of serum prealbumin at baseline and its changes over 6 mo were examined in a 5-y (2001–2006) cohort of 798 patients receiving MHD.

Results: Patients with serum prealbumin ≥ 40 mg/dL had greater mid-arm muscle circumference but lower percentage of total body fat. Both serum interleukin-6 and dietary protein intake correlated independently with serum prealbumin. Measures of QoL indicated better physical health, physical function, and functionality with higher prealbumin concentrations. Although baseline prealbumin was not superior to albumin in predicting survival, in both all and normoalbuminemic (albumin ≥ 3.5 g/dL; n = 655) patients, prealbumin < 20 mg/dL was associated with higher death risk in adjusted models, but further adjustments for inflammatory cytokines mitigated the associations. In 412 patients with baseline prealbumin between 20 and 40 mg/dL whose serum prealbumin was remeasured after 6 mo, a ≥10-mg/dL fall resulted in a death hazard ratio of 1.37 (95% CI: 1.02, 1.85; P = 0.03) after adjustment for baseline measures, including inflammatory markers.

Conclusions: Even though baseline serum prealbumin may not be superior to albumin in predicting mortality in MHD patients, prealbumin concentrations <20 mg/dL are associated with death risk even in normoalbuminemic patients, and a fall in serum prealbumin over 6 mo is independently associated with increased death risk.




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
C. P Kovesdy, S. M George, J. E Anderson, and K. Kalantar-Zadeh
Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease
Am. J. Clinical Nutrition, August 1, 2009; 90(2): 407 - 414.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
R. Shantouf, C. P. Kovesdy, Y. Kim, N. Ahmadi, A. Luna, C. Luna, M. Rambod, A. R. Nissenson, M. J. Budoff, and K. Kalantar-Zadeh
Association of Serum Alkaline Phosphatase with Coronary Artery Calcification in Maintenance Hemodialysis Patients
Clin. J. Am. Soc. Nephrol., June 1, 2009; 4(6): 1106 - 1114.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The American Society for Nutrition